中性粒细胞与淋巴细胞和血小板比值对脓毒症患者28天死亡率的预测价值
该回顾性研究纳入江苏大学附属医院ICU 2017年6月至2020年6月收治的脓毒症患者,最终分析50例(28天存活30例、死亡20例)。诊断脓毒症后3天内检测外周血中性粒细胞、淋巴细胞和血小板计数,计算N/LPR和NLR。死亡组N/LPR和NLR均显著高于存活组(P<0.01)。N/LPR预测28天死亡的AUC为0.827,优于NLR的0.762;N/LPR≥15.48时敏感度75.0%、特异度80.0%。N/LPR≥15.48组28天死亡率71.4%,显著高于<15.48组的17.2%(P<0.01)。
要点
- 脓毒症患者诊断后3天内N/LPR≥15.48预测28天死亡,敏感度75.0%、特异度80.0%,AUC 0.827。
- N/LPR预测28天死亡的AUC(0.827)高于NLR(0.762),NLR≥10.65时特异度仅56.7%。
- N/LPR≥15.48组28天死亡率71.4%(15/21),显著高于N/LPR<15.48组的17.2%(5/29),P<0.01。
- NLR≥10.65组28天死亡率53.6%(15/28),高于NLR<10.65组的22.7%(5/22),P<0.05。
- 死亡组N/LPR为23.85±11.99、NLR为17.83±8.69,均显著高于存活组的12.41±5.25和10.75±3.63(均P<0.01)。
适用人群与场景
- ICU收治的脓毒症患者,以ICU首次诊断脓毒症为研究起点。
- 排除年龄<18岁、妊娠、血液病、1周内服用阿司匹林或其他抗血小板药、1周内服用升白细胞药、ICU住院<3天及资料不完整者。
- 最终纳入50例,28天存活30例、死亡20例。
诊断标准与关键阈值
- N/LPR计算公式为中性粒细胞计数与淋巴细胞和血小板计数乘积的比值(原文未给出具体公式细节,仅报告比值结果)。
- N/LPR预测28天死亡的最佳截断值为≥15.48,敏感度75.0%、特异度80.0%。
- NLR预测28天死亡的最佳截断值为≥10.65,敏感度75.0%、特异度56.7%。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为单中心回顾性分析,初始收集154例脓毒症患者,最终纳入50例(存活30例、死亡20例)。
- 死亡组N/LPR显著高于存活组(23.85±11.99 vs. 12.41±5.25,P<0.01),NLR亦显著升高(17.83±8.69 vs. 10.75±3.63,P<0.01)。
- N/LPR预测28天死亡的AUC为0.827,高于NLR的AUC 0.762。
- N/LPR≥15.48组(n=21)28天死亡率为71.4%,显著高于N/LPR<15.48组(n=29)的17.2%(χ2=14.901,P<0.01)。
- NLR≥10.65组(n=28)28天死亡率为53.6%,高于NLR<10.65组(n=22)的22.7%(χ2=4.884,P<0.05)。
- Kaplan-Meier生存曲线分析结果与上述亚组分析一致。
证据类型、等级与局限
- 证据类型为单中心回顾性研究,样本量小(最终纳入50例),原文未给出证据等级或推荐强度。
- 局限性包括回顾性设计、单中心、样本量小(初始154例仅50例纳入分析),可能存在选择偏倚。
对床旁实践的改变
- 对ICU脓毒症患者,可在诊断后3天内计算N/LPR,N/LPR≥15.48提示28天死亡风险较高(死亡率71.4% vs. 17.2%),可辅助早期风险分层。
- N/LPR预测价值优于NLR,NLR≥10.65时特异度仅56.7%,临床解读需谨慎。
- 该指标适用于排除血液病、妊娠、近期服用抗血小板或升白细胞药物且ICU住院≥3天的脓毒症患者,不适用于上述排除人群。
- 原文未提及基于N/LPR的干预措施,不能据此改变治疗决策。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the value of neutrophil to lymphocyte and platelet ratio (N/LPR) for predicting 28-day mortality in sepsis patients.
METHODS: A retrospective analysis was conducted. The clinical data of 154 sepsis patients admitted to intensive care unit (ICU) of the Affiliated Hospital of Jiangsu University from June 2017 to June 2020 were enrolled. The time of first diagnosis of sepsis in ICU was taken as the research starting point, and the death or 28 days as the end point. The 28-day outcomes of patients were recorded. The counts of peripheral blood neutrophil (NEU), lymphocyte (LYM) and platelet (PLT) were collected from all the enrolled patients within 3 days after diagnosis of sepsis. The ratios of N/LPR and NEU/LYM (NLR) were calculated respectively. The differences of N/LPR and NLR between survival group and death group were compared. Receiver operating characteristic (ROC) curve analysis was used to analyze the value of N/LPR and NLR on predicting the 28-day mortality of sepsis patients. According to the best cut-off value of ROC curve analysis, the 28-day mortality of patients with sepsis was analyzed by subgroup analysis, and the 28-day cumulative survival of patients with sepsis was analyzed by Kaplan-Meier survival curve.
RESULTS: Of the 154 sepsis patients, the patients with age < 18 years, pregnancy, blood disease, taking aspirin or other antiplatelet drugs within 1 week, taking leucocyte drugs within 1 week, length of ICU stay < 3 days and incomplete data were excluded. Finally, 50 patients were enrolled. Among them, 30 patients survived on the 28th day and 20 died. Compared with the survival group, the levels of N/LPR and NLR in the death group were significantly increased (N/LPR: 23.85±11.99 vs. 12.41±5.25, NLR: 17.83±8.69 vs. 10.75±3.63), with statistical differences (both P < 0.01). ROC curve analysis indicated that the area under ROC curve (AUC) of N/LPR for predicting 28-day death of sepsis patients was 0.827, it was higher than that of NLR (AUC = 0.762). Base on N/LPR ≥ 15.48 as a predictor of cut-off value of death in 28 days of sepsis patients, the sensitivity was 75.0% and the specificity was 80.0%, respectively. Base on NLR ≥ 10.65 as a predictor of cut-off value of death in 28 days of sepsis patients, the sensitivity was 75.0% and specificity was 56.7%, respectively. Subgroup analysis showed that the 28-day mortality in the patients with N/LPR ≥ 15.48 (n = 21) was significantly higher than those with N/LPR < 15.48 (n = 29; 71.4% vs. 17.2%, χ2 = 14.901, P < 0.01); and the 28-day mortality in the patients with NLR ≥ 10.65 (n = 28) was also significantly higher than those with NLR < 10.65 (n = 22; 53.6% vs. 22.7%, χ2 = 4.884, P < 0.05). The results were consistent with Kaplan-Meier survival curve analysis.
CONCLUSIONS: Peripheral blood N/LPR has a good predictive value for 28-day mortality of sepsis patients, and which is better than NLR.
参考来源
- Liu D, Yu Z, Zhang D, et al. [Value of neutrophil to lymphocytes and platelets ratio for predicting 28-day mortality in sepsis patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 33565397. doi:10.3760/cma.j.cn121430-20200727-00545
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。